FIELD: medicine.
SUBSTANCE: there are offered an oral pharmaceutical composition containing a) a testosterone ester and a fatty acid ester of a medium chain size; and b) two or more lipid ingredients, at least first of which contains a hydrophilic surfactant and at least second of which contains a lipophilic surfactant; said lipid ingredients together provide solubilisation of said testosterone ester in amount 10-20 % of weight of a pharmaceutical composition; a method for prevention or release of testosterone deficiency symptoms in mammal subjects and a method for maintenance of prolonged oral testosterone release.
EFFECT: invention provides medium-size testosterone and fatty acid ester delivery of intensified and prolonged adsorption, desired testosterone levels which are detected in people who do not suffer testosterone deficiency.
30 cl, 15 dwg, 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL DELIVERY SYSTEMS FOR HYDROPHOBIC MEDICINAL PRODUCTS AND COMPOSITIONS CONTAINING THEM | 2006 |
|
RU2623206C2 |
| ORAL PHARMACEUTICAL COMPOSITIONS OF TESTOSTERONE ESTERS AND METHOD FOR TESTOSTERONE SHORTAGE TREATMENT WITH THEIR USE | 2010 |
|
RU2642244C2 |
| LONG-CHAIN LIPOSBALANCED ESTERS OF TESTOSTERONE FOR ORAL DELIVERY | 2014 |
|
RU2722592C2 |
| PHARMACEUTICAL COMPOSITION AS AN MICROEMULSION WITH BIOLOGICALLY ACTIVE MACROMOLECULAR MATERIAL AND A METHOD OF ITS PREPARING | 1989 |
|
RU2122403C1 |
| PERORAL COMPOSITIONS CONTAINING ESTER 17- HYDROXYPROHESTERON, AND CORRESPONDING METHODS | 2012 |
|
RU2640912C2 |
| COMPOSITION COMPRISING TESTOSTERONE UNDECANOATE AND CASTOR OIL | 2000 |
|
RU2246296C2 |
| ORAL DISINTEGRATING DOSAGE FORM OF AVANAFIL AND RELATED METHODS FOR PREPARING AND USING IT | 2015 |
|
RU2740903C2 |
| ORAL PHARMACEUTICAL COMPOSITIONS BASED ON PRODUCTS CONTAINING LIPASES, FIRST OF ALL PANCREATINE, AND SURFACTANTS | 2005 |
|
RU2381813C2 |
| OIL-IN-WATER EMULSION AND USE THEREOF IN ENDOWING FUNCTIONALITY | 2006 |
|
RU2426440C2 |
| SELF-MICROEMULSIFIED ORAL PHARMACEUTICAL COMPOSITION CONTAINING HYDROPHILIC THERAPEUTIC AGENT, AND METHOD FOR PREPARING IT | 2010 |
|
RU2532362C2 |
